Literature DB >> 8846687

The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion.

N J Wareham, D I Phillips, C D Byrne, C N Hales.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8846687     DOI： 10.1111/j.1464-5491.1995.tb00399.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  58 in total

1.  Impact of family history of diabetes on β-cell function and insulin resistance among Chinese with normal glucose tolerance.

Authors:  Gang Chen; Meizhi Li; Yuan Xu; Nianhui Chen; Huibin Huang; Jixing Liang; Liantao Li; Junping Wen; Lixiang Lin; Jin Yao
Journal:  Diabetes Technol Ther       Date:  2012-03-09       Impact factor: 6.118

2.  Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.

Authors:  Lotte Usinger; Katrine B Hansen; Viggo B Kristiansen; Steen Larsen; Jens J Holst; Filip K Knop
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

3.  Comparison of time course changes in blood glucose, insulin and lipids between high carbohydrate and high fat meals in healthy young women.

Authors:  Yoomi Shin; Soojin Park; Ryowon Choue
Journal:  Nutr Res Pract       Date:  2009-06-30       Impact factor: 1.926

4.  An abnormal screening glucose challenge test in pregnancy predicts postpartum metabolic dysfunction, even when the antepartum oral glucose tolerance test is normal.

Authors:  Ravi Retnakaran; Ying Qi; Mathew Sermer; Philip W Connelly; Anthony J G Hanley; Bernard Zinman
Journal:  Clin Endocrinol (Oxf)       Date:  2008-10-21       Impact factor: 3.478

5.  Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes.

Authors:  G W Mills; P J Avery; M I McCarthy; A T Hattersley; J C Levy; G A Hitman; M Sampson; M Walker
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

6.  Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes.

Authors:  Sheena Kayaniyil; Reinhold Vieth; Ravi Retnakaran; Julia A Knight; Ying Qi; Hertzel C Gerstein; Bruce A Perkins; Stewart B Harris; Bernard Zinman; Anthony J Hanley
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 19.112

7.  Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).

Authors:  Chamukuttan Snehalatha; Simon Mary; Sundaram Selvam; Cholaiyil Kizhakathil Sathish Kumar; Samith Babu Ananth Shetty; Arun Nanditha; Ambady Ramachandran
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

8.  Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.

Authors:  Amélie Bonnefond; Martine Vaxillaire; Yann Labrune; Cécile Lecoeur; Jean-Claude Chèvre; Nabila Bouatia-Naji; Stéphane Cauchi; Beverley Balkau; Michel Marre; Jean Tichet; Jean-Pierre Riveline; Samy Hadjadj; Yves Gallois; Sébastien Czernichow; Serge Hercberg; Marika Kaakinen; Susanne Wiesner; Guillaume Charpentier; Claire Lévy-Marchal; Paul Elliott; Marjo-Riitta Jarvelin; Fritz Horber; Christian Dina; Oluf Pedersen; Robert Sladek; David Meyre; Philippe Froguel
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

9.  Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response.

Authors:  C Langenberg; L Pascoe; A Mari; A Tura; M Laakso; T M Frayling; I Barroso; R J F Loos; N J Wareham; M Walker
Journal:  Diabetologia       Date:  2009-05-20       Impact factor: 10.122

10.  Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial.

Authors:  Anthony J Hanley; Bernard Zinman; Patrick Sheridan; Salim Yusuf; Hertzel C Gerstein
Journal:  Diabetes Care       Date:  2009-12-15       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.